Indications for Low-Dose Aspirin in Pregnancy
Low-dose aspirin (81 mg/day) prophylaxis is recommended for pregnant women at high risk of preeclampsia and should be initiated between 12-16 weeks of gestation and continued daily until delivery. 1, 2, 3
High-Risk Factors (Single Factor Sufficient for Aspirin Prophylaxis)
- History of preeclampsia, especially early-onset preeclampsia with delivery <34 weeks
- Multifetal gestation
- Chronic hypertension
- Type 1 or type 2 diabetes
- Renal disease
- Autoimmune diseases (such as systemic lupus erythematosus or antiphospholipid syndrome)
Moderate-Risk Factors (Multiple Factors Required for Aspirin Prophylaxis)
Aspirin prophylaxis should be considered when multiple moderate risk factors are present:
- First pregnancy (nulliparity)
- Maternal age ≥35 years
- BMI >30 kg/m²
- Family history of preeclampsia (mother or sister)
- Sociodemographic characteristics (low socioeconomic status)
- Personal history factors
Dosing and Timing
- The recommended dose is 81 mg daily according to ACOG and USPSTF 1, 2
- Alternative dosing recommendations include:
- WHO: 75 mg/day
- RCOG: 150 mg/day 1
- Initiation should occur between 12-16 weeks of gestation (optimally before 16 weeks) 1, 2, 3
- Therapy should continue until delivery 1
Clinical Benefits
Low-dose aspirin prophylaxis in high-risk women has been shown to:
- Reduce preeclampsia risk by 24% 4, 1
- Reduce preterm birth risk by 14% 4, 1
- Reduce intrauterine growth restriction by 20% 4, 1
Safety Considerations
- Low-dose aspirin during pregnancy is considered safe with minimal risk of serious maternal or fetal complications 2, 3
- The FDA notes that aspirin should generally be avoided during the last 3 months of pregnancy unless specifically directed by a doctor, as it may cause problems in the unborn child or complications during delivery 5
- However, in the specific context of preeclampsia prevention, the benefits of continuing low-dose aspirin until delivery outweigh the risks 1
Important Clinical Caveats
- Aspirin prophylaxis is most effective when started before 16 weeks of gestation 1, 6
- Despite ACOG recommendations, studies have shown mixed results regarding efficacy in all high-risk groups 4, 7
- In the absence of high-risk factors for preeclampsia, current evidence does not support prophylactic low-dose aspirin for prevention of early pregnancy loss, fetal growth restriction, stillbirth, or preterm birth 2, 3
- Patient education about medication adherence is crucial for effective preeclampsia prevention 1
Risk Assessment Algorithm
- Evaluate for presence of any high-risk factors
- If ≥1 high-risk factor present → prescribe low-dose aspirin (81 mg daily)
- If no high-risk factors, evaluate for moderate-risk factors
- If ≥2 moderate-risk factors present → prescribe low-dose aspirin (81 mg daily)
- Initiate therapy between 12-16 weeks gestation
- Continue therapy until delivery
- Monitor for adherence and any adverse effects
This approach aligns with current ACOG and USPSTF guidelines to identify women who would benefit most from preeclampsia prevention with low-dose aspirin.